Tuesday, May 8, 2012
FDA staff: Gilead's Truvada may help reduce HIV risk
WASHINGTON (Reuters) - Gilead Sciences Inc's Truvada tablets appear safe and effective for reducing the risk of HIV infection, U.S. regulators said on Tuesday. But they recommended a cautious approach for using the drug in efforts to prevent the virus that causes AIDS. 
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment